Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

Add To Watchlist

Bullboard (TSX:MSCL)

View:

(0)
•••

Post by PressReleaseon Sep 13, 2022 9:07am

New Press Release - Satellos Bioscience Inc. Announces Closing of Offering of Units

Toronto, Ontario--(Newsfile Corp. - September 13, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce the closing of its...read article.

(0)
•••

Post by PressReleaseon Sep 07, 2022 4:02pm

New Press Release - Satellos Bioscience Inc. Announces the Filing of Final Short Form Prospectus for Proposed Offering of Units

Toronto, Ontario--(Newsfile Corp. - September 7, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed its final...read article.

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 24, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Comment by beenthereon Sep 05, 2022 4:35pm

RE:And this one!

Negative that's why!!

174

Discussion

Post by beenthereon Sep 05, 2022 4:35pm

And this one!

Satellos Bioscience Inc. Announces Pricing of Proposed Offering of Units NewsfileAug 30, 2022 8:09 PM EDT Toronto, Ontario--(Newsfile Corp. - August 30, 2022) - Satellos Bioscience ...more

394

Discussion

Post by beenthereon Sep 05, 2022 4:33pm

Or this one

Satellos Bioscience Inc. Announces the Filing of an Amended and Restated Preliminary Prospectus for Proposed Offering of Units NewsfileAug 29, 2022 8:53 PM EDT Toronto, Ontario ...more

324

Post by beenthereon Sep 05, 2022 4:29pm

What about this one?

Satellos Bioscience Reports Q2 2022 Financials and Operating Results NewsfileAug 29, 2022 7:06 PM EDT Toronto, Ontario--(Newsfile Corp. - August 29, 2022) - Satellos Bioscience Inc ...more

326

Comment by beenthereon Sep 05, 2022 4:15pm

RE:New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Awarded Significant Grant from the Canadian Institutes of Health Research

Why is this here and NOT the other news releases?

Discussion

(0)
•••

Post by PressReleaseon Jul 25, 2022 7:01am

New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Awarded Significant Grant from the Canadian Institutes of Health Research

Toronto, Ontario--(Newsfile Corp. - July 25, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...read article.

Comment by beenthereon Jul 17, 2022 7:41am

RE:RE:.018 per share pre-consolidation nice

And they didn't even last a year before they start diluting us! Unreal!

156

Discussion

Comment by G1945Von Jul 15, 2022 8:05am

RE:RE:.018 per share pre-consolidation nice

Let's see what the preliminary short form prospectus will bring forth, if it does close on July 28, 2022? G1945V

115

Discussion

Comment by Itistooon Jul 14, 2022 7:48pm

RE:.018 per share pre-consolidation nice

Sure has been, market isn't helping right now but it really didn't seem like they were ready to go public and overestimated peoples interest in the company. Feels like its at the bottom right ...more

164

Discussion

Post by Drambueyon Jul 13, 2022 5:07pm

.018 per share pre-consolidation nice

What a joke this company is, azzclowns running this POS.

190

Discussion

(0)
•••

Post by PressReleaseon Jul 13, 2022 7:01am

New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Published in Nature Communications

Toronto, Ontario--(Newsfile Corp. - July 13, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...read article.

(0)
•••

Post by PressReleaseon Jul 11, 2022 3:41pm

New Press Release - Satellos Bioscience Inc. Announces Proposed Offering of Units

Toronto, Ontario--(Newsfile Corp. - July 11, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has filed a preliminary...read article.

Post by db2067on Jul 04, 2022 10:02am

Defeat Duchenne Canada

https://musculardystrophynews.com/2022/06/16/defeat-duchenne-canada-grants-1m-dmd-treatment-research/ Defeat Duchenne Canada grant recipients for this year include Michael Rudnicki, PhD, director of ...more

180

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:MSCL)